ANNOUNCEMENT 26 May 2010

On 26 May 2010, the EIB provided financing worth EUR 50 million (USD 63 million).

NUMBER OF INTERVENTIONS

1

  • 1 harmful
  • 0 neutral
  • 0 liberalising
Inception date: 26 May 2010 | Removal date: open ended

State loan

On 26 May 2010, the European Investment Bank (EIB) and Bial Portela & Ca Sa. signed an agreement worth EUR 50 million (approx. USD 63 million) for the project Bial Inovacao Rdi from Portugal. The total cost of the project is estimated at EUR 120 million.

According to the project description issued by the EIB, The project concerns the promoters R&D-activities in the period 2010 up to and including 2012, with a focus on drugs for epilepsy, cardiovascular affections and Parkinsons disease..

The objective of the project is defined as following: Contribute to private sector investments in R&D..

A state act in the GTA database is assessed solely in terms of the extent to which its implementation affects foreign commercial interests. On this metric, the investment support granted here is discriminatory.

AFFECTED SECTORS

 
N/A

AFFECTED PRODUCTS

 
N/A